2. Alfarouk KO, Stock CM, Taylor S, Walsh M, Muddathir AK, Verduzco D,
et al. Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell Int 2015;15:71.
3. Majewska M, Lewandowska U. The chemopreventive and anticancer potential against colorectal cancer of polyphenol rich fruit extracts. Food Rev Int 2018;34:390–409.
5. Sreelatha S, Jeyachitra A, Padma PR. Antiproliferation and induction of apoptosis by
Moringa oleifera leaf extract on human cancer cells. Food Chem Toxicol 2011;49:1270–1275.
6. Deshmukh AV, Gupta A, Chaudhari AG, Gangane NM. Correlation of p53 expression with clinical presentation and prognosis of oral squamous cell carcinoma patients: a pilot study. Indian J Otolaryngol Head Neck Surg 2020 Apr 22 [Epub].
https://doi.org/10.1007/s12070-020-01859-0.
7. Puteri A, Meizarini A. p53: the guardian of genome against OSCC progression. Eur J Mol Clin Med 2020;7:1071–1079.
8. Lindemann A, Takahashi H, Patel AA, Osman AA, Myers JN. Targeting the DNA Damage response in OSCC with
TP53 nutations. J Dent Res 2018;97:635–644.
9. Zanaruddin SN, Yee PS, Hor SY, Kong YH, Ghani WM, Mustafa WM,
et al. Common oncogenic mutations are infrequent in oral squamous cell carcinoma of Asian origin. PLoS One 2013;8:e80229.
11. Zhou G, Liu Z, Myers JN.
TP53 mutations in head and neck squamous cell carcinoma and their impact on disease progression and treatment response. J Cell Biochem 2016;117:2682–2692.
12. Hientz K, Mohr A, Bhakta-Guha D, Efferth T. The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget 2017;8:8921–8946.
13. Neskey DM, Osman AA, Ow TJ, Katsonis P, McDonald T, Hicks SC,
et al. Evolutionary action score of TP53 identifies high-risk mutations associated with decreased survival and increased distant metastases in head and neck cancer. Cancer Res 2015;75:1527–1536.
14. Osman AA, Neskey DM, Katsonis P, Patel AA, Ward AM, Hsu TK,
et al. Evolutionary action score of TP53 coding variants is predictive of platinum response in head and neck cancer patients. Cancer Res 2015;75:1205–1215.
15. Phillips MA, Stewart MA, Woodling DL, Xie ZR. Has molecular docking ever brought us a medicine?. In: Molecular Docking (Vlachakis DP, ed.). London: Intech Open, 2018. pp. 141–178.
16. Poornima C, Agnihotri PG, Rajan SY, Padmavathi BN, Guruprasad R. The role of P53 in oral cancer: a review. J Indian Acad Oral Med Radiol 2005;17:153–156.
17. McCoy JG, Bingman CA, Wesenberg GE, Phillips GN Jr, Center for Eukaryotic Structural Genomics (CESG). Crystal structure a TP53-induced glycolysis and apoptosis regulator protein from
Homo sapiens. Protein Data Bank, 2017. Accessed 2021 Oct 1. Available from:
http://doi.org/10.2210/pdb3DCY/pdb.
18. Sravani M, Kumaran A, Dhamdhere AT, Kumar NS. Computational molecular docking analysis and visualisation of anthocyanins for anticancer activity. Int J Res Appl Sci Biotechnol 2021;8:154–161.
20. Anwar F, Latif S, Ashraf M, Gilani AH. Moringa oleifera: a food plant with multiple medicinal uses. Phytother Res 2007;21:17–25.
21. Mohanty M, Mohanty S, Bhuyan SK, Bhuyan R. Phytoperspective of
Moringa oleifera for oral health care: an innovative ethnomedicinal approach. Phytother Res 2021;35:1345–1357.
22. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3–26.
23. Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 2004;1:337–341.
24. de Brito MA. Pharmacokinetic study with computational tools in the medicinal chemistry course. Braz J Pharm Sci 2011;47:797–805.
28. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS,
et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–2791.
29. Yuan S, Chan HS, Hu Z. Using PyMOL as a platform for computational drug design. WIRES Comput Mol Sci 2017;7:e1298.
30. Ghanghoria S, Ghanghoria A, Shukla A. 2015. p53 expression in oral cancer: a study of 50 cases. J Pathol Nepal 2015;5:747–751.
31. May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 1999;18:7621–7636.
32. Wang Y, Xing J, Xu Y, Zhou N, Peng J, Xiong Z,
et al.
In silico ADME/T modelling for rational drug design. Q Rev Biophys 2015;48:488–515.
33. Plewczynski D, Lazniewski M, Augustyniak R, Ginalski K. Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database. J Comput Chem 2011;32:742–755.
34. Ismail NZ, Annamalai N, Zain NN, Arsad H. Molecular docking of selected compounds from
Clinacanthus nutans with BCL-2, p53, caspase-3 and caspase-8 proteins in the apoptosis pathway. J Biol Sci Opin 2020;8:4–11.